Dr. Fallon’s lab studies neurogenesis, targeting Alzheimer's and other secondary conditions. The Executive Chairman of Bolden, Charlie Polsky, a prominent member of the Chicago life sciences start-up ecosystem, will be key to maximizing the potential of this license agreement. Brown Technology Innovations is continuing to explore with Dr. Fallon how Bolden could use the license.
Brown Technology Innovations
Date
August 1, 2020
Exclusive license option to Bolden for research in Justin Fallon’s Lab
Justin Fallon, Professor of Medical Science, Professor of Psychiatry and Human Behavior, has optioned intellectual property to Bolden, his newest startup.